MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Healthcare Medical Devices

MedMira Inc. is a Canada-based biotechnology company. The Company, through its subsidiaries, is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. The Company invests in research in order to maintain and expand its position in the global diagnostics market. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. The Company is the developer and owner of Rapid Vertical Flow (RVF) Technology. The Company's rapid test applications built on RVF Technology provide hospitals, labs, clinics and individuals with instant diagnosis for diseases such as Human Immunodeficiency Virus (HIV), Syphilis and hepatitis C in just three easy steps. The Company's tests are sold under the Reveal, Multiplo and Miriad brands in global markets. The Company's manufacturing facilities are located in Halifax, Nova Scotia, Canada.

TSXV:MIR - Post by User

MedMira Inc

Bullboard Posts

Comment by Park1on Nov 12, 2015 11:49am

64 Views

Post# 24285311

RE:twinklers

I didn't post that post in hopes of MedMira for or of failing. I was asking if the Syphilis/HIV test that is submitted to the WHO fell into the category of the old HIV test.? Quote:- Halifax, Nova Scotia, March 11, 2013 MedMira Inc., (MedMira) (TSXV: MIR), a developer of rapid diagnostic technology and solutions, announced today that it has submitted an application for its Multiplo Syphilis/HIV rapid test (also known as Multiplo TP/HIV) to the World Health Organization (WHO) Prequalification of Diagnostics program. The Company received a letter of invitation from the WHO to submit Multiplo Syphilis/HIV for prequalification. This invitation comes as MedMiras Reveal HIV rapid test is in the final stages of the WHO prequalification program.

Bullboard Posts

Parliament looks for your word on potential Chinese-made EV tariffs